Cyclopropylmescaline

Cyclopropylmescaline
Names
	Preferred IUPAC name 2-[4-(Cyclopropylmethoxy)-3,5-dimethoxyphenyl]ethan-1-amine
	Other names 4-Cyclopropylmethoxy-3,5-methoxy-phenethylamine; 4-Cyclopropylmethoxy-3,5-methoxy-1-ethane
Identifiers
CAS Number	207740-23-6 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL421458 ;
ChemSpider	21106288 ;
PubChem CID	44350143;
UNII	D9268U4GS8 ;
CompTox Dashboard (EPA)	DTXSID60658384 ;
	InChI InChI=1S/C14H21NO3/c1-16-12-7-11(5-6-15)8-13(17-2)14(12)18-9-10-3-4-10/h7-8,10H,3-6,9,15H2,1-2H3 Key: LNTBHKZMYJTHTH-UHFFFAOYSA-N ; InChI=1/C14H21NO3/c1-16-12-7-11(5-6-15)8-13(17-2)14(12)18-9-10-3-4-10/h7-8,10H,3-6,9,15H2,1-2H3 Key: LNTBHKZMYJTHTH-UHFFFAOYAG;
	SMILES COc2cc(cc(OC)c2OCC1CC1)CCN;
Properties
Chemical formula	C14H21NO3
Molar mass	251.326 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Cyclopropylmescaline (CPM or 4-cyclopropylmethoxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. CPM was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 60–80 mg and the duration listed as 12–18 hours. CPM produces closed-eye imagery, visuals, and fantasies. It also causes enhancement of music. Very little data exists about the pharmacological properties, metabolism, and toxicity of CPM. The drug acts as a serotonin 5-HT₂ receptor agonist.